牛传染性鼻气管炎基因工程疫苗研究进展

Abstract

Abstract: Infectious bovine rhinotracheitis (IBR) is a highly contagious, infectious disease that is caused by bovine herpes-virus-1(BHV-1). In addition to causing respiratory disease, this virus can cause conjunctivitis, abortions, encephalitis, andgeneralized systemic infections. IBR was originally recognized during the early 1950’s in Colorado feedlots. There is no direct treatment for the infection and the best way to control IBR is to vaccinate before a disease outbreak occurs. Nowadays, conventional IBR vaccines have been, and still are, routinely used in many countries, the glycoprotein E (gE)-deleted vaccines, either as a live or as a inactivated vaccine, have been commercialized in the European Union. In this review, we discussed the progress in development of gene-deleted vaccine, subunit vaccine, viral vector vaccine and DNA vaccine.

Key words: infectious bovine rhinotracheitis; gene-deleted vaccine; subunit vaccine; viral vector vaccine; DNA vaccine

CLC Number:

S859.79

XU Qiong, HE Yu-qian, WU Hai-yan. Progress in Development of Genetic Engineering Vaccines against Infectious Bovine Rhinotracheitis[J]. , 2012, 39(11): 52-56.

References

1 李长友, 秦德超, 肖肖. 一二三类动物疫病释义[M]. 北京: 中国农业出版社, 2011.
2 Abdelmagid O Y, Mansour M M, Okwumabua O, et al. Expression and cellular distribution of baculovirus-expressed bovine herpesvirus 1 (BHV-1) glycoprotein D (gD) sequences[J]. Archives of Virology, 1998, 143 (11): 2173~2187.
3 Bosch J C, Kaashoek M J, Kroese A H, et al. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines[J]. Veterinary Microbiology, 1996, 52 (3~4): 223~234.
4 Braun R P, Babiuk L A, Loehr B I, et al. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1[J]. Virology, 1999, 265 (1): 46~56.
5 Chase C C, Carter-Allen K, Lohff C, et al. Bovine cells expressing bovine herpesvirus 1 (BHV-1) glycoprotein Ⅳ resist infection by BHV-1, herpes simplex virus, and pseudorabies virus[J]. Journal of Virology, 1990, 64 (10): 4866~4872.
6 Cox G J, Zamb T J, Babiuk L A. Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA[J]. Journal of Virology, 1993, 67 (9): 5664~5667.
7 Denis M, Hanon E, Rijsewijk F A, et al. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1[J]. Veterinary Microbiology, 1996, 53 (1~2): 121~132.
8 Dispas M, Schynts F, Lemaire M, et al. Isolation of a glycoprotein E-deleted bovine herpesvirus type 1 strain in the field[J]. Veterinary Record, 2003, 153 (7): 209~212.
9 Ferrer M F, Del Medico Zajac M P, Zanetti F A, et al. Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models[J]. Viral Immunology, 2011, 24 (4): 331~339.
10 Gogev S, de Fays K, Versali M F, et al. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1[J]. Vaccine, 2004, 22 (15~16): 1946~1953.
11 Ioannou X P, Griebel P, Hecker R, et al. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus emulsigen are increased by formulation with CpG oligodeoxynucleotides[J]. Journal of Virology, 2002, 76 (18): 9002~9010.
12 Kaashoek M J, Rijsewijk F A, Ruuls R C, et al. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene[J]. Vaccine, 1998, 16 (8): 802~809.
13 Khattar S K, Collins P L, Samal S K. Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1[J]. Vaccine, 2010, 28 (18): 3159~3170.
14 Langellotti C A, Pappalardo J S, Quattrocchi V, et al. Induction of specific cytotoxic activity for bovine herpesvirus-1 by DNA immunization with different adjuvants[J]. Antiviral Research, 2011, 90 (3): 134~142.
15 Lemaire M, Schynts F, Meyer G, et al. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: Influence of virus load and effect of specific maternal antibodies[J]. Vaccine, 2001, 19 (32): 4795~4804.
16 Makoschey B, Franken P, Mars J M, et al. IBR and BVD control: The key to successful herd management[J]. Berliner und Munchener Tierarztliche Wochenschrift, 2010, 123 (11~12): 516~518, 519~521.
17 Mars M H, de Jong M C, Franken P, et al. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field[J]. Vaccine, 2001, 19 (15~16): 1924~1930.
18 Miller N J. Infectious necrotic rhinotracheitis of cattle[J]. Journal of the American Veterinary Medical Association, 1955, 126 (939): 463~467.
19 Petrini S, Ramadori G, Corradi A, et al. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves[J]. Comparative Immunology, Microbiology and Infectious Diseases, 2011, 34 (1): 3~10.
20 Rijsewijk F A, Kaashoek M J, Langeveld J P, et al. Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains[J]. Archives of Virology, 2000, 145 (5): 921~936.
21 Robinson K E, Meers J, Gravel J L, et al. The essential and non-essential genes of bovine herpesvirus 1[J]. Journal of General Virology, 2008, 89 (Pt 11): 2851~2863.
22 van Donkersgoed J, McCartney D, van Drunen Littel-van den Hurk S. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol[J]. Canadian Journal of Veterinary Research, 1996, 60 (1): 55~58.
23 van Drunen Littel-van den Hurk S, Parker M D, Massie B, et al. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV[J]. Vaccine, 1993, 11 (1): 25~35.
24 van Drunen Littel-van den Hurk S, Snider M, Thompson P, et al. Strategies for induction of protective immunity to bovine herpesvirus-1 in newborn calves with maternal antibodies[J]. Vaccine, 2008, 26 (25): 3103~3111.
25 van Engelenburg F A, Kaashoek M J, Rijsewijk F A, et al. A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves[J]. Journal of General Virology, 1994, 75 (Pt 9): 2311~2318.
26 van Oirschot J T. Diva vaccines that reduce virus transmission[J]. Journal of Biotechnology, 1999, 73 (2~3): 195~205.
27 Zakhartchouk A N, Pyne C, Mutwiri G K, et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: Induction of protective immunity to bovine herpesvirus-1[J]. Journal of General Virology, 1999, 80 (5): 1263~1269.
28 Zhu X, Letchworth G J. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle[J]. Vaccine, 1996, 14 (1): 61~69.
29 Zhu X, Wu S, Letchworth G J. Yeast-secreted bovine herpesvirus type 1 glycoprotein D has authentic conformational structure and immunogenicity[J]. Vaccine, 1997, 15 (6~7): 679~688.

[1]	ZHAO Fengmiao, GUO Ting, ZHOU Yaping, ZHAO Hongmei, WANG Yuchen, TIAN Guangyuan, SUN Yajie, BIAN Yuchen, YU Jialiang, HAO Yongqing. Pathogenicity Analysis of Bovine Viral Diarrhea Virus and Immune Effect Evaluation of E2 Protein in New Zealand White Rabbits [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(9): 3549-3558.
[2]	PAN Chenhao, ZHANG Xin, ZHAO Ruili, JIANG Xuan, JIN Tianming, YU Enyuan, LI Liuan, ZENG Jun, YU Xiaoxue, SONG Qiqi, HU Ye. Construction and Cytotoxicity Detection of Recombinant Epitope Protein DCpep-GSE of Streptococcus suis [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(8): 2990-3001.
[3]	ZHU Weifeng, CHEN Lu, WANG Fang, HU Bo, RUAN Zhiyang, WANG Gaojie. Study on Immunoprotective Efficacy of Pasteurella Glycolytic Enzymes [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(6): 2188-2195.
[4]	XU Xuelin, YANG Bo, JING Huansong, HU Yinghong, WANG Fenghua, SUN Peihao, XIONG Jiajun. Construction and Stability Study of Co-expression Castration DNA Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(5): 1745-1754.
[5]	YANG Shuai, ZHANG Xinxin, ZHOU Di, YUAN Jing, YANG Liguo. Study on the Growth Promoting Effect of Crossbred Buffalo Growing Cattle Immunized with DNA Vaccine of Co-expression of Somatostatin and Cortistatin [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(4): 1361-1369.
[6]	WANG Ning, ZHAO Pengpeng, ZHANG Yanyan, MA Xun, WANG Zhengrong, BO Xinwen. Research Progress on DNA Vaccine Against Animal Parasite [J]. China Animal Husbandry and Veterinary Medicine, 2021, 48(3): 1034-1045.
[7]	FENG Yaya, GUO Jing, LI Yubao, LIU Cheng, LI Xuyong. Review of DNA Vaccine for Avian Influenza [J]. China Animal Husbandry and Veterinary Medicine, 2020, 47(11): 3667-3675.
[8]	JI Wenheng, WU Yaqin, ZHAI Xiaohui, CHU Yuefeng. Advances on the Research of Vaccine Against Mycoplasma bovis [J]. , 2018, 45(3): 763-769.
[9]	WU Jing, XU Jian, HUANG Xiu-fen, SHEN Jun-jun, HE Hou-jun, LI Yong-qing. Expression and Biological Activity of Single Chain Antibody Against gD Glycoprotein of Infectious Bovine Rhinotracheitis Virus in Insect Cells [J]. , 2017, 44(8): 2475-2482.
[10]	WANG Li-bo, WU Run-sheng, YAN Chao, LV Tun. Effects of Different Adjuvants on the Immunogenicity of PCV2-Cap Protein [J]. , 2016, 43(11): 3037-3046.
[11]	WU Zhi, HAO Fu-xing, WANG Yong-juan, LIU Yang, WANG Dong, XU Zhou, YUAN Wei-feng. Construction of Specifically Targeted Chimeric Canine Parvovirus DNA Vaccine and Its Efficacy Assessment [J]. , 2016, 43(10): 2768-2774.
[12]	MA Xing-shu. Research Progress on Vaccines of Avian Colibacillosis [J]. , 2015, 42(1): 234-244.
[13]	SUN Jian-tao, HOU Shao-hua, YU Ping, ZHU Hong-fei, LIANG Qian, HAO Zhi-ming. Study on the Construction and Expression Characteristics of Canine Distemper DNA Vaccine Based on SFV-replicon [J]. , 2013, 40(9): 96-100.
[14]	LIU Chun-ju, REN Wei-jie, WANG Zhi-liang. Research Progress on Application of Baculovirus Expression System in Veterinary Subunit Vaccine Field [J]. , 2013, 40(9): 101-105.
[15]	SU Yan, WANG Shi-ming, SHAO Jun-gao, ZHANG Bao-jiang, WEI Hai-na, LI Ying. Study on the Immungenicity of Bovine Staphylococcus aureus Fibronectin-binding Protein A (FnbpA) Secretory DNA Vaccine in Mice [J]. , 2013, 40(2): 27-30.

Progress in Development of Genetic Engineering Vaccines against Infectious Bovine Rhinotracheitis

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments